Skip to content

To see the effect of Basti and Virechana in Scleroderma

Evaluation of Parisheka Basti and Virechana with Navkarshik Kwath in Vatarakta with special reference to Scleroderma

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035099
Enrollment
20
Registered
2021-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M341- CR(E)ST syndrome

Interventions

Intervention1: Hapushadi Yapana Basti & Anuvasana Basti: Hapushadi Yapana Basti Dose- Hapusha, Yava, Godugdha, Sneha , Saindhava, Madhu- (Dose will depend on patient bal and prakriti), Anuvasana Basti

Sponsors

PATANJALI AYURVED COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 20-60 years; 2. Patients fulfil the criteria of Vatarakta (Scleroderma); 3. Patients with Limited Cutaneous Systemic Sclerosis (LCSS); 4. CREST (Calcinosis, Raynaudâ??s, Oesophageal involvement, Sclerodactyly and Telangiectasia) Syndrome; 5. Chronicity between 6 weeks to 10 years with not less than 30% involvement of body surface.; 6. Digital Ulcers; 7. Patients who are fit for Basti Karma and Virechana Karma

Exclusion criteria

Exclusion criteria: 1. Age less than 20 and more than 60 years; 2. Diffuse Cutaneous Systemic Sclerosis; 3. Patients with traumatic, malignant and chronic wound; 4. Pregnancy & lactating mothers; 5. Any other systemic disorders; 6. Patients who are unfit for Basti Karma and Virechana Karma

Design outcomes

Primary

MeasureTime frame
Subjective parameters: 1.Twak Kathinta (Skin Hardening) 2.Twak Vaivarnyata (Raynaudâ??s Phenomenon) 3.Sandhishotha (Joint Swelling) 4.Stabdhata (Stiffness) 5.Paka / Twak Lohita (Digital Ulcer) Associated Symptoms: 1.Shula (Pain) 2.Kandu (Itching) 3.Daha (Burning sensations) 4.Jwara (Fever)Timepoint: 30 days

Secondary

MeasureTime frame
Objective parameters: 1.Modified Rodnan Skin Score (mRSS) 2.Involvement of Body Surface Area 3.Digital Ulcer Size 4.Discharge 5.ESR 6.Antinuclear Antibody Titers 7.CRPTimepoint: 30 days

Countries

India

Contacts

Public ContactPIYUSH GUPTA

PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN

drpiyushgupta3@gmail.com8954890277

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026